Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity

Chrysothemis C Brown1, Herman Gudjonson2, Yuri Pritykin3

  • 1Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Infection, Inflammation and Rheumatology Section, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.

Cell
|November 1, 2019
PubMed

Insights

Researchers discovered two new dendritic cell (DC) types, cDC2a and cDC2b, crucial for immune responses. These distinct DC subsets, identified through advanced analysis, have unique developmental paths and functions, offering new insights into adaptive immunity and cancer.

Area of Science:

  • Immunology
  • Cell Biology
  • Transcriptional Regulation

Background:

  • Dendritic cells (DCs) are key orchestrators of adaptive immunity, initiating T cell responses.
  • Classical DCs comprise cDC1 and cDC2 subsets, with cDC1 transcriptional regulation well-studied, but cDC2 development and function remain less understood.

Purpose of the Study:

  • To elucidate the poorly understood development and function of classical dendritic cell subset 2 (cDC2).
  • To identify distinct lineages within the cDC2 population and their regulatory mechanisms.

Main Methods:

  • Integrated transcriptional profiling and chromatin analysis.
  • Utilized genetic reporter expression to track DC development.
  • Comparative analysis across species to identify conserved mechanisms.

Main Results:

  • Identified two principal cDC2 lineages with distinct developmental pathways.
  • Discovered novel transcriptional regulators, including T-bet and RORγt, defining these cDC2 lineages.
  • Characterized unique metabolic and functional programs for each new cDC2 subset.
  • Confirmed the presence of these conserved cDC2 subsets in human cancer samples.

Conclusions:

  • Dendritic cell heterogeneity extends beyond previously defined subsets.
  • Two novel cDC2 lineages, regulated by T-bet and RORγt, exhibit distinct functional programs.
  • These findings reveal conserved DC diversity in humans and implications for understanding immune responses in cancer.

Related Concept Videos